Condition
Myelodysplastic Syndrome (MDS) clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Myelodysplastic Syndrome (MDS) clinical trials that are recruiting, at sites in 3 countries (most in United States (3), China (1), Japan (1)). By phase: Phase 1 (2), Phase 1/2 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Myelodysplastic Syndrome (MDS) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Evaluating TQB3455 Tablets for Patients with Blood Cancers | Phase 1 | Beijing, Beijing Municipality and 6 other locations | Recruiting | Aug 13, 2024 |
| CLN-049 treatment for patients with relapsed or refractory AML or MDS | Phase 1/2 | Birmingham, Alabama and 16 other locations | Recruiting | Dec 3, 2021 |
| Testing a new oral medication for patients with Myelodysplastic Syndrome | Phase 1 | Bunkyō City and 9 other locations | Recruiting | Oct 29, 2020 |
| Using umbilical cord blood to improve transplant outcomes for severe blood disorders | Phase 1/2 | Bethesda, Maryland | Recruiting | Jun 2, 2017 |
| Transplant for Patients with Fanconi Anemia Using Adjusted Chemotherapy | Phase 2 | New York, New York and 2 other locations | Recruiting | May 21, 2014 |
All recruiting trials (5)
-
Evaluating TQB3455 Tablets for Patients with Blood Cancers
This study is testing a new tablet called TQB3455 to see if it is safe and effective for people with blood cancers like acute myeloid leukemia and myelodysplastic syndrome.
-
CLN-049 treatment for patients with relapsed or refractory AML or MDS
This study is testing a new treatment called CLN-049 to see if it can help patients with relapsed or hard-to-treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS).
-
Testing a new oral medication for patients with Myelodysplastic Syndrome
This study is testing a new oral medication for adults with Myelodysplastic Syndrome to see if it works as well as the standard injectable treatment.
-
Using umbilical cord blood to improve transplant outcomes for severe blood disorders
This study is testing whether using a mix of blood stem cells from a family member and umbilical cord blood can help improve transplant success for people aged 4-60 with severe blood disorders like aplastic anemia and myelodysplastic syndrome.
-
Transplant for Patients with Fanconi Anemia Using Adjusted Chemotherapy
This study is testing a new way to use lower doses of chemotherapy before a stem cell transplant to see if it can safely help people with Fanconi anemia and serious blood disorders.
Related topics
Quick answers
How many Myelodysplastic Syndrome (MDS) clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), China (1 trial), Japan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.